Presentation slides and video from the 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates were presented in Los Angeles, CA and virtually on September 20, 2023.
Program Organizers
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.
Program Learning Objectives
Describe the mechanisms of monoclonal antibodies and antibody-drug conjugates.
Summarize recent updates in the use of monoclonal antibodies and antibody-drug conjugates clinically.
Outline common toxicities with monoclonal antibodies and antibody-drug conjugates and their management.
You can view the program agenda here.
Please note on-demand recordings are not available for continuing education credits.
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Date: September 20, 202300:32:34
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Aashini K. Master, DO; Date: September 20, 202300:28:59
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Arun Singh, MD; Date: September 20, 202300:23:14
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Sidharth R. Anand, MD, MBA; Date: September 20, 202300:16:46
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Lidia Lopez, NP; Date: September 20, 202300:15:52
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Madelaine C. Kuiper, NP; Date: September 20, 202300:13:28
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Monica Mead, MD; Date: September 20, 202300:12:31
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Caspian Oliai, MD; Date: September 20, 202300:12:25
Meeting: 2023 Advances in Cancer Immunotherapy™ Series: A Focus on Monoclonal Antibodies and Antibody-drug Conjugates; Speaker: Sidharth R. Anand, MD, MBA; Date: September 20, 202300:09:48